MedTrace Logo

S(+)-Ibuprofen Effects on Asprin Treated Volunteers

NCT00442585 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2012-03-13

No results posted yet for this study

Summary

The purpose of this clinical trial is to determine whether S(+)-ibuprofen affect the platelet inhibition under steady state acetylsalicylic acid conditions.

Conditions

  • Drug Interactions

Interventions

DRUG

S(+)-ibuprofen

Sponsors & Collaborators

  • Gebro Pharma GmbH

    lead INDUSTRY

Principal Investigators

  • Christian Joukhadar, MD · Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, Medical Univerisity of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Completion
2007-10-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00442585 on ClinicalTrials.gov